Pfizer and Moderna stocks tumble over anticipated low COVID-19 vaccination rate

  • 📰 dcexaminer
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 94%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

Pfizer, BioNTech, and Moderna stock prices fell precipitously on Monday as a result of anticipated low uptake rates for the updated COVID-19 vaccines.

Pfizer CFO David Denton said at a press conference on Monday that he anticipates 24% of the U.S. population, or 82 million people, will receive the updated COVID-19 vaccines that received approval from the Food and Drug Administration last week.As of May, only 17% of the nation had received the bivalent booster vaccination against COVID-19, according to data from the Centers for Disease Control and Prevention.

Pfizer and BioNTech announced on Tuesday of last week at a CDC advisory meeting that they would be charging approximately $120 for their mRNA COVID-19 vaccines, while Moderna would be charging closer to $130. The Biden administration announced in July that it would begin commercializing the COVID-19 preparedness strategy, only relying upon government-purchased vaccines for those without insurance or with insurance that would not cover the updated shot.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 6. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Stocks making the biggest moves midday: Marathon Petroleum, Tesla, Moderna and moreThese are the stocks posting the largest moves in midday trading.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »